Dr. Irene Ang Dy, MD

Dr. Dy practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Dy's NPI, 1528393063, was assigned on October 15, 2009. Dr. Dy holds California license A120038.

Dr. Dy's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Dy's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Dy is also affiliated with Kadlec Regional Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Dy to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dy practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dy's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Dy is licensed in California.

CMS data shows 601 Medicare services from Dr. Dy across 4 procedure codes in 2024, for 419 Medicare patients. Medicare paid $44,898 for them. Every service was in an office.

CMS counts 419 Medicare patients who saw Dr. Dy in 2024. The largest group is 75 to 84, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dy's median patient age at 73, with 59% women.

In 2024, Dr. Dy wrote 233 Medicare Part D claims for 66 patients. 75% of them were for generic drugs. CMS names the drug for 90 of them, across 5 drugs with 11 or more claims each, at $1,584 in total drug cost. In 2023, CMS named 114 claims across 6 drugs.

Dr. Dy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dy as offering telehealth.

Dmand AI links 5 papers to Dr. Dy, published from 2011 to 2012. 2011 was the busiest year, with 2. The most frequent topics are Cocaine, Cocaine-Related Disorders and Levamisole. Dr. Dy's most frequent co-authors are Tareq Al Baghdadi, MD, Daniel Jacob Becker, MD and Charles David Blanke, MD.

Dmand AI links Dr. Dy to 6 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. SWOG Cancer Research Network sponsors the most, 3.

CMS Open Payments shows 313 general payments to Dr. Dy from 41 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $779.